Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Aptamer Regulated Transcription For In-Vitro Sensing And Transduction

Published Patent Application Number: WO 2024/118806

Problem

(a) Without an aptamer’s protein ligand, dARTs are transcribed to produce RNA outputs (left), while protein binding represses transcription (middle). The input and output domains are decoupled (right), enabling modular design of dARTs by swapping out the aptamer domain or customizing the output sequences. (b) dARTs serve as the protein sensing layer (left) whose outputs can be coupled with downstream circuits (middle). RNA outputs are measured via fluorescence (right).

Molecular biosensors that accurately measure protein concentrations without external equipment are critical for solving numerous problems in diagnostics, therapeutics, and biomanufacturing; yet modularly transducing the binding of protein antibodies, protein switches, or aptamers into a useful output remains challenging.

Invention

It relates to nucleic acid transcription templates, systems, and methods for detection and measurement of molecules and biomolecules (e.g., biomarkers). Particularly, systems and methods utilize a transcription template with an aptamer domain configured to bind a molecule of interest to regulate production of a transcribed output ribonucleic acid (RNA). 

Potential Commercial Applications

Clinical diagnostics, protein sensing, biomanufacturing.

Competitive Advantage

The new method enables facile development of inexpensive and rapid biosensors for molecular detection and measurement.

Created July 11, 2024, Updated September 17, 2025
Was this page helpful?